| Symbol | TSX : AMB |
|---|---|
| Last trade | 0.07 |
| Volume | 20,620 |
| As of | 2008-11-20 13:07 EST |
| Note: Quotes are delayed. For informational purposes only. |
|
Shareholder information
Head Office
Ambrilia Biopharma Inc.
1000 chemin du Golf
Verdun, Quebec H3E 1H4
Tel.: (514) 751-2003
Fax: (514) 751-2502
www.ambrilia.com
Stock Listing
Listing: Toronto Stock Exchange (TSX)
Symbol: AMB
Transfer Agent and Registrar
Computershare Investor Services
1500 University Street, 7th Floor
Montreal, Quebec H3A 3S8
Tel.: (514) 982-7888
Auditors
Ernst & Young LLP
Corporate Counsel
Fasken Martineau DuMoulin LLP
Annual General Meeting of Shareholders 2007
The 2007 Annual General Meeting of Shareholders of Ambrilia was held on Tuesday, June 10, 2008, at 10:30 am ET, at:
Centre Mont-Royal
2200 Mansfield Street
Montreal, Quebec H3A 3R8
Tel: (514) 844-2000
Investor Information and Inquiries
Contact: Philippe Calais, Ph.D., Pharm.
President & CEO
Tel.: (514) 751-2003 ext. 235
e-mail: pcalais@ambrilia.com or
ir@ambrilia.com
All filings for Ambrilia Biopharma Inc. are available through SEDAR.